Compass Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Compass Therapeutics, Inc. has filed 355 SEC EDGAR filings since 30 May 2018

SEC filing history

Showing 351-355 of 355 matching filings.

Per page
25
Current page
15
10-Q File 000-55939

QUARTERLY REPORT

Filing date
14 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
10-Q File 000-55939

QUARTERLY REPORT

Filing date
14 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
3

3 filing

Filing date
30 Jul 2018
Reporting date
29 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
30 Jul 2018
Reporting date
29 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-12G File 000-55939

GENERAL FORM FOR REGISTRATION OF SECURITIES

Filing date
30 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .